🟢 Indaptus Therapeutics is trading 10.4% up today after a roughly $24 million private placement

Indaptus Therapeutics is trading 10.43% up now at $3.06 as investors continue responding to the September 10 private-placement announcement.

• Financing covers 20,338,974 shares and approximately $24 million in gross proceeds
• Proceeds target working capital, research and development, and general corporate purposes
• The stock advanced 8.20% on September 11 and 23.08% on September 10